Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription

Articles published in Cancer

Retrieve available abstracts of 28 articles:
HTML format

Single Articles

    October 2020
  1. YIN K, Singh P, Drohan B, Hughes KS, et al
    Breast imaging, breast surgery, and cancer genetics in the age of COVID-19.
    Cancer. 2020;126:4466-4472.
    PubMed     Abstract available

    June 2020
  2. IBRAHEEM A, Olopade OI, Huo D
    Propensity score analysis of the prognostic value of genomic assays for breast cancer in diverse populations using the National Cancer Data Base.
    Cancer. 2020 Jun 10. doi: 10.1002/cncr.32956.
    PubMed     Abstract available

  3. DANCIU OC, Chen Z, Hoskins KF
    If you don't measure it, you can't improve it: Success and shortcomings of genomic assays in early breast cancer.
    Cancer. 2020 Jun 10. doi: 10.1002/cncr.32955.

    March 2020
  4. PASSARO A, Malapelle U, Attili I, de Marinis F, et al
    Overcoming resistance to osimertinib in non-small cell lung cancer: Hopes, doubts, and in-between.
    Cancer. 2020 Mar 10. doi: 10.1002/cncr.32810.

    February 2020
    Experts say more women should be tested for BRCA1 and BRCA2 genetic mutations.
    Cancer. 2020;126:693.

    August 2019
    Epigenetics and differential effects of aspirin on breast cancer survival: Opportunities for understanding human susceptibility and risk.
    Cancer. 2019 Aug 12. doi: 10.1002/cncr.32365.

    July 2019
  7. WANG H, Ou Q, Li D, Qin T, et al
    Genes associated with increased brain metastasis risk in non-small cell lung cancer: Comprehensive genomic profiling of 61 resected brain metastases versus primary non-small cell lung cancer (Guangdong Association Study of Thoracic Oncology 1036).
    Cancer. 2019 Jul 9. doi: 10.1002/cncr.32372.
    PubMed     Abstract available

    June 2019
  8. KESSLER MD, Bateman NW, Conrads TP, Maxwell GL, et al
    Ancestral characterization of 1018 cancer cell lines highlights disparities and reveals gene expression and mutational differences.
    Cancer. 2019;125:2076-2088.
    PubMed     Abstract available

    November 2018
  9. SIMONETTI G, Padella A, do Valle IF, Fontana MC, et al
    Aneuploid acute myeloid leukemia exhibits a signature of genomic alterations in the cell cycle and protein degradation machinery.
    Cancer. 2018 Nov 27. doi: 10.1002/cncr.31837.
    PubMed     Abstract available

    October 2018
  10. HOSKINS KF, Tejeda S, Vijayasiri G, Chukwudozie IB, et al
    A feasibility study of breast cancer genetic risk assessment in a federally qualified health center.
    Cancer. 2018 Oct 15. doi: 10.1002/cncr.31635.
    PubMed     Abstract available

  11. GORNICK MC, Kurian AW, An LC, Fagerlin A, et al
    Knowledge Regarding and Patterns of Genetic Testing in Patients Newly Diagnosed With Breast Cancer Participating in the iCanDecide Trial.
    Cancer. 2018 Oct 5. doi: 10.1002/cncr.31731.
    PubMed     Abstract available

    September 2018
  12. KUMAR R, Liu APY, Orr BA, Northcott PA, et al
    Advances in the classification of pediatric brain tumors through dna methylation profiling: from research tool to frontline diagnostic.
    Cancer. 2018 Sep 26. doi: 10.1002/cncr.31583.
    PubMed     Abstract available

    April 2018
  13. SPIGEL DR, Burris HA 3rd, Greco FA, Shih KC, et al
    Erlotinib plus either pazopanib or placebo in patients with previously treated advanced non-small cell lung cancer: A randomized, placebo-controlled phase 2 trial with correlated serum proteomic signatures.
    Cancer. 2018 Apr 12. doi: 10.1002/cncr.31290.
    PubMed     Abstract available

  14. ARBOUR KC, Riely GJ
    Improving therapy for patients with epidermal growth factor receptor-mutant lung cancer.
    Cancer. 2018 Apr 12. doi: 10.1002/cncr.31289.

    January 2018
  15. ROSS JS, Fakih M, Ali SM, Elvin JA, et al
    Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations in ERBB2 and ERBB3.
    Cancer. 2018 Jan 16. doi: 10.1002/cncr.31125.
    PubMed     Abstract available

    November 2017
  16. ALI SM, Ross JS, Wang K
    Reply to Genomic profiles of nasopharyngeal carcinoma: The importance of histological subtyping and Epstein-Barr virus in situ assays.
    Cancer. 2017 Nov 22. doi: 10.1002/cncr.31132.

  17. LUI VWY, To KF, Lo KW
    Genomic profiles of nasopharyngeal carcinoma: The importance of histological subtyping and Epstein-Barr virus in situ assays.
    Cancer. 2017 Nov 22. doi: 10.1002/cncr.31131.

    September 2017
  18. MCWILLIAMS RR, Foster NR, Mahoney MR, Smyrk TC, et al
    North Central Cancer Treatment Group N0543 (Alliance): A phase 2 trial of pharmacogenetic-based dosing of irinotecan, oxaliplatin, and capecitabine as first-line therapy for patients with advanced small bowel adenocarcinoma.
    Cancer. 2017;123:3494-3501.
    PubMed     Abstract available

    June 2017
  19. JOHNSON LM, Valdez JM, Quinn EA, Sykes AD, et al
    Integrating next-generation sequencing into pediatric oncology practice: An assessment of physician confidence and understanding of clinical genomics.
    Cancer. 2017;123:2352-2359.
    PubMed     Abstract available

  20. BERRY AB
    Analytic inquiry: Validation and practical considerations.
    Cancer. 2017;125.
    PubMed     Abstract available

  21. HANNA MG, Pantanowitz L
    The role of informatics in patient-centered care and personalized medicine.
    Cancer. 2017;125.
    PubMed     Abstract available

    April 2017
  22. BURKARD ME, Deming DA, Lauring J
    Using cancer genomics to guide clinical decisions.
    Cancer. 2017;123:1288-1291.

    January 2017
  23. TALHOUK A, McConechy MK, Leung S, Yang W, et al
    Confirmation of ProMisE: A simple, genomics-based clinical classifier for endometrial cancer.
    Cancer. 2017 Jan 6. doi: 10.1002/cncr.30496.
    PubMed     Abstract available

  24. PRINTZ C
    First person: Margaret Spitz, MD, MPH.
    Cancer. 2017;123:9-10.

    August 2016
  25. CREUTZIG U, Zimmermann M, Reinhardt D, Rasche M, et al
    Changes in cytogenetics and molecular genetics in acute myeloid leukemia from childhood to adult age groups.
    Cancer. 2016 Aug 16. doi: 10.1002/cncr.30220.
    PubMed     Abstract available

  26. DESAI NB, Scott SN, Zabor EC, Cha EK, et al
    Genomic characterization of response to chemoradiation in urothelial bladder cancer.
    Cancer. 2016 Aug 1. doi: 10.1002/cncr.30219.
    PubMed     Abstract available

    June 2016
  27. ROSS JS, Gay LM, Wang K, Ali SM, et al
    Nonamplification ERBB2 genomic alterations in 5605 cases of recurrent and metastatic breast cancer: An emerging opportunity for anti-HER2 targeted therapies.
    Cancer. 2016 Jun 10. doi: 10.1002/cncr.30102.
    PubMed     Abstract available

    May 2016
  28. GALLOWAY-PENA JR, Smith DP, Sahasrabhojane P, Ajami NJ, et al
    The role of the gastrointestinal microbiome in infectious complications during induction chemotherapy for acute myeloid leukemia.
    Cancer. 2016 May 3. doi: 10.1002/cncr.30039.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Genetics is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.